What is Healogics?
Established in 1996, Healogics specializes in the comprehensive treatment of chronic wounds. Their advanced care services cater to a diverse patient population suffering from conditions such as diabetic ulcers, surgical wounds, venous ulcers, pressure ulcers, trauma wounds, and arterial ulcers. The company's focus on specialized wound management positions it as a key player in the healthcare services sector, addressing a critical need within patient care.
How much funding has Healogics raised?
Healogics has raised a total of $165M across 1 funding round:
Private Equity
$165M
Private Equity (2021): $165M with participation from Marathon Asset Management
Key Investors in Healogics
Marathon Asset Management
Marathon Asset Management is a significant financial entity, with its affiliate MCAP Global Finance (UK) LLP specializing in investment management services. Their involvement suggests a strategic financial backing for Healogics' growth initiatives.
What's next for Healogics?
The recent major strategic investment of $165M signals Healogics' intent to further expand its capabilities and market reach. This significant backing, part of its $165M in total financing, will likely fuel advancements in treatment methodologies, technology adoption, and potentially geographic expansion. The company is poised to leverage this capital to enhance its service offerings and solidify its leadership in the specialized field of advanced wound care.
See full Healogics company page
